Skip to content

Author

Marie Ménard

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Abstract B073: Rational combination strategies enhance the depth and durability of zoldonrasib antitumor response in preclinical models of KRAS G12D pancreatic cancer

R Rational combination strategies of zoldonrasib with mechanistically distinct agents can enhance antitumor activity relative to the respective monotherapies, and potentially delay emergence of resistance to RAS(ON) inhibition in preclinical models of KRAS G12D PDAC.

Urszula N. Wasko, Yong-Xian Zhuang, Marie Ménard et al. · 0 citations
Sep 2026

Abstract B053: RAS(ON) inhibition, but not chemotherapy, sensitizes RAS mutant PDAC to immunotherapy via tumor microenvironment remodeling in preclinical models

Pancreatic ductal adenocarcinoma (PDAC) remains largely refractory to immune checkpoint blockade and combining anti-PD-(L)1 therapy with standard-of-care chemotherapy has not improved clinical outcomes over chemotherapy alone. Because oncogenic RAS drives both tumor growth and tumor-intrinsic immune suppression, we h...

L. Grigoryan, Keith Macaraig, Victor Batiste et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.